ILIVBIO

Ilivbio is a South Korean biotechnology company specializing in the research and development of functional bio-materials derived from natural products. Founded in 2022, the company focuses on addressing metabolic disorders, such as diabetes and obesity, through evidence-based natural solutions. Its core research centers on Ice Plant Extract (IPE) and D-pinitol, which have demonstrated efficacy in improving insulin secretion and managing blood glucose levels in pre-clinical and clinical studies. Ilivbio has already commercialized several functional health products, including antioxidants and eye health supplements, while advancing its pipeline of proprietary natural extracts. The company maintains strategic partnerships with leading research institutions like KIST and Gachon University to validate the safety and efficacy of its candidates.